Marinus Pharmaceuticals
MRNS
$1.51
Share price
4.14%
Change (1 day)
-83.22%
Change (1 year)
Categories
Marinus Pharmaceuticals (MRNS) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.15 B
According to Marinus Pharmaceuticals's latest financial reports the company's total liabilities are $0.15 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Marinus Pharmaceuticals - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.15 B | 7.4% |
| 2022-12-31 | $0.14 B | 72.18% |
| 2021-12-31 | $83.35 M | 528.47% |
| 2020-12-31 | $13.26 M | 19.78% |
| 2019-12-31 | $11.07 M | 60.27% |
| 2018-12-31 | $6.9 M | 159.35% |
| 2017-12-31 | $2.66 M | -73.27% |
| 2016-12-31 | $9.96 M | -21.68% |
| 2015-12-31 | $12.72 M | 40.49% |
| 2014-12-31 | $9.05 M | 282.88% |
| 2013-12-31 | $2.36 M | -47.42% |
| 2012-12-31 | $4.49 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | $0.35 B | 131.06% | 🇺🇸 USA |
 Endo International
ENDPQ | $11.73 B | 7,513.00% | 🇮🇪 Ireland |
 AcelRx Pharmaceuticals
ACRX | $6.29 M | -95.92% | 🇺🇸 USA |
 Eagle Pharmaceuticals
EGRX | $0.15 B | -0.88% | 🇺🇸 USA |